Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan in Hypertensive Patients With Stable Heart Failure
NCT00417222Phase 3Completed
- Sponsor
- Tohoku University
- Start
- Nov 2006
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olmesartan in chronic heart failure (CHF), hypertension (HTN), sponsored by Tohoku University. Started Nov 2006; status: completed.
02
Drugs
olmesartan
03
Conditions
chronic heart failure (CHF)hypertension (HTN)
Beyond the preview
Go deeper on NCT00417222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417222.